Capsule Endoscopy vs. Push Enteroscopy in Occult Gastrointestinal Bleeding OGIB
2007年3月23日 更新者:Assistance Publique - Hôpitaux de Paris
Efficiency of Capsule Endoscopy and Push Enteroscopy in Obscure Gastrointestinal Bleeding. A Prospective Randomized Study.
Capsule endoscopy (CE) is a safe and effective tool for the assessment of obscure gastrointestinal bleeding (OGIB).
However, its real efficacy and its position in the diagnostic algorithm of OGIB vs. push enteroscopy (PE) remain unknown since in previous studies both techniques were performed in all included patients The purpose of this protocol is to conduct a randomized prospective controlled trial in patients with OGIB comparing a strategy based on CE or PE followed by the alternative exploration only when the first line exploration was negative.
The main outpoint of this study concerns the diagnostic yield of the two explorations.
Second endpoint concerns the clinical relevance of the two strategies tested (CE ± PE vs. CE ± PE) in terms of diagnostic yield, clinical outcome, therapeutic impact and added explorations
研究概览
详细说明
This was a prospective randomized multicentric study.
After the screening visit, eligible subjects were randomly assigned to be explored by CE or PE (first line exploration).
The alternative exploration was only performed if no diagnosis was evidenced by the examination assigned by randomization.
An independent staff member assigned subjects in 1:1 ratio between CE and PE strategies with stratification for overt and occult bleeding and centers according to consecutive number that were kept in serialized sealed opaque envelopes.
After the completion of these explorations, the patients returned at month 3, 6 and 12 thereafter.
At each visit, clinical evaluation and laboratory tests were performed and patients were managed according to published recommendations2 (AGA medical position).
The first line exploration as well as the alternative exploration could be done during the one year follow-up period only in case of severe relapse of OGIB or necessity to perform biopsies or a therapeutic procedure.
研究类型
介入性
注册
45
阶段
- 第三阶段
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
-
Paris、法国、75015
- Hôpital Europeén Georges Pompidou
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 及以上 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
- Patients may suffer from episodes of active bleeding within the last 6 months or chronic iron-deficiency anemia (hemoglobin < 10 g/dl).
- A gynecologic or proctologic bleeding source had to be excluded.
- All patients had to have negative workup including upper gastrointestinal endoscopy, colonoscopy and small-bowel barium series or computed tomography enteroclysis.
- Medical reports and/or the imaging documents were available and reviewed in all patients. Usually these investigations were repeated several times before inclusion.
- Abdominal angiography was only performed when there were signs of active bleeding during the diagnostic work-up (n = 3). Meckel scintigraphy was usually carried out in patients under 30 years of age (n = 14).
Exclusion Criteria:
- Patient presenting a digestive bleeding with an echo hemodynamic major and\or requiring urgent therapeutic measures
- Wait presenting a gynaecological cause or a cause proctology of sure imputability or syndrome of malabsorption or deficiency of contribution not formally excluded
- Patient presenting an occlusive syndrome or a hurt of stenosis hail objectivized by a radiological exploration
- Surrounding wall(Speaker) or in age waits to procreate without effective contraception
- The mental or physical state of the patient not allowing a maid compliance in the conditions of the try(essay) and or in the correct use of the device Patient carrier of a pacemaker or another electromechanical implant
- Patient that must undergo an examination by MRI before having been able to eliminate the capsule
- Enteroscopy or video capsule prerequisite technically satisfactory and in touch with same pathological episode or dating at least less than 6 months Patient participating at present in another clinical trial without direct profit which can directly or indirectly influence the results(profits) of the present study
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:诊断
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
研究衡量的是什么?
主要结果指标
结果测量 |
|---|
|
The primary end point was the diagnostic yield of CE and PE (first line exploration allocated by randomization) for the identification of a definitive source of bleeding.
|
次要结果测量
结果测量 |
|---|
|
Secondary end points were evaluated at the end of the follow up period and concerned the clinical relevance of the two strategies (PE ± CE vs. CE ± PE). They included: (1) the diagnostic yield of the two strategies for the identification of a definitive
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Raymond JIAN, MD、Assistance Publique - Hôpitaux de Paris
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2002年3月1日
研究完成 (实际的)
2005年6月1日
研究注册日期
首次提交
2005年9月16日
首先提交符合 QC 标准的
2005年9月16日
首次发布 (估计)
2005年9月23日
研究记录更新
最后更新发布 (估计)
2007年3月26日
上次提交的符合 QC 标准的更新
2007年3月23日
最后验证
2007年3月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.